Approval · Notice of Compliance 2249 · 2001
PEPCID I.V.: Notice of Compliance 2249
Issued November 30, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2249
- Date
- November 30, 2001
- Company
- Merck Frosst Canada & Cie, Merck Frosst Canada & Co.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph revisions: safety update
- Therapeutic class
- Histamine h2 receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PEPCID I.V. | Not yet assigned | — |
Medicinal ingredients
- FAMOTIDINE 10 MG per ML